Access cutting-edge lung cancer treatment through this clinical trial at a research site in Newark. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Newark at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
The primary objectives are to compare progression-free survival (PFS) and overall survival (OS) in participants who receive sotorasib with platinum doublet chemotherapy versus participants who receive pembrolizumab with platinum doublet chemotherapy.
Sponsor: Amgen
Check if you qualify for this lung cancer clinical trial in Newark, DE
If you're searching for lung cancer treatment options in Newark, DE, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Newark research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.